01541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 2.95
+1.55%Leverage
- Debt / equity
- 0.58x
- Net debt / equity
- -0.45x
- Debt / assets
- 0.35x
- Debt / EBITDA
- -1.79x
- Net debt / EBITDA
- 1.40x
Liquidity & coverage
- Current ratio
- 2.66x
- Quick ratio
- 2.66x
- Cash ratio
- 2.54x
- Interest coverage
- -29.24x
- EBITDA / interest
- -29.08x
- Working capital
- HKD 727.9M
Cash & dividend
- FCF / debt
- -0.65x
- Cash flow / debt
- -0.64x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026